Noopur Raje, MD, Massachusetts General Hospital

Articles

Dr. Raje on the Rationale for CAR T-Cell Therapy in Multiple Myeloma

June 29th 2020

Noopur Raje, MD, discusses the rationale for CAR T-cell therapy in multiple myeloma.

Dr. Raje on Future Research With BiTEs in Multiple Myeloma

April 25th 2020

Noopur Raje, MD, discusses future research with bispecific T-cell engagers in multiple myeloma.

Dr. Raje on the Potential Utility of Belantamab Mafodotin in Multiple Myeloma

April 24th 2020

Noopur Raje, MD, discusses the potential utility of belantamab mafodotin in multiple myeloma.

Dr. Raje on Data With AMG 420 in Multiple Myeloma

March 18th 2020

Noopur Raje, MD, director, Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, and professor of medicine, Harvard Medical School, discusses data with AMG 420 in multiple myeloma.

Dr. Raje on the Efficacy of Belantamab Mafodotin in Multiple Myeloma

March 5th 2020

Noopur Raje, MD, discusses the utility of belantamab mafodotin in the treatment of patients with multiple myeloma.

Dr. Raje Compares Data for Triplet Regimens in Myeloma

April 18th 2019

Noopur Raje, MD, professor of medicine at Harvard Medical School and director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center, discusses data for the standard triplet regimens in the treatment of patients with relapsed/refractory myeloma.

Dr. Raje on Treatment Approaches for Relapsed/Refractory Myeloma

April 8th 2019

Noopur Raje, MD, professor of medicine at Harvard Medical School and director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center, discusses treatment approaches for patients with relapsed/refractory multiple myeloma.

Dr. Raje on bb21217 in Multiple Myeloma

March 15th 2019

Noopur Raje, MD, professor of medicine at Harvard Medical School and director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center, discusses preliminary data on bb21217 in multiple myeloma.

Dr. Raje on Quadruplet Regimens in Myeloma

October 1st 2018

Noopur Raje, MD, director, Center for Multiple Myeloma, Massachusetts General Hospital, discusses the potential of quadruplet regimens in the multiple myeloma treatment paradigm.

Dr. Raje Discusses the Impact of bb2121in Myeloma

September 12th 2018

Noopur Raje, MD, director, Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, discusses the impact of bb2121 in myeloma.

Dr. Raje Discusses the Tolerability of bb2121 in Myeloma

June 25th 2018

Noopur Raje, MD, director Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, discusses the tolerability of bb2121 as a treatment for patients with multiple myeloma.

Dr. Raje Discusses Anti-CD38 Antibodies in Myeloma

December 8th 2014

Noopur Raje, MD, from the Multiple Myeloma Program at Massachusetts General Hospital, discusses the unprecedented efficacy seen with monoclonal antibodies as treatments for patients with multiple myeloma.